CMIC Group offers greatly expanded services that encompass an entire value-chain of pharmaceutical companies, including manufacturing, sales, and marketing. We also provide services to medical device manufacturers, academia, bio-ventures, and medical institutions. In addition, we offer prophylaxis and health enhancing services to the public.
CMIC identifies and offers e-solutions suited to individual projects, including a wide range of IT services, thereby contributing to improved quality and speed in clinical studies.
We provide effective support services to meet our clients’ needs by using the accumulated expertise and know-how of clinical research/trial with CMIC Group’s cooperative support system.
We dispatch or introduce personnel specialize in the pharmaceutical and medical industries with deep expertise, good business manners, and communication skills. We can dispatch or introduce highly reliable and fully trained personnel who are capable of handling wide range of tasks.
Developed by CMIC, “RENAPRO®L-FABP Test” is the world’s first diagnostic reagent to measure urinary L-type fatty acid binding protein (L-FABP), which has garnered attention as a novel biomarker of renal disease.
We offer "patient support program" based on the experiences of building website and making brochures.
We provide services utilizing know-how based on our accumulated experiences of medical marketing and medical call center.
Call operators with MR qualifications will provide information to doctors.
We will contribute to reduction of MR cost and resolution of MR resource shortage at the time of new product launch by video chat etc.
CMIC Group can provide solutions consolidating total power and knowledge of clinical trials for patient recruitment.
We established the online patient community "helC" with the aim of establishing patient-centered care. Based on the patient information database, we propose data use type disease awareness.